PRIA Logo™
IllinoisHB3454104th General Assembly (2025–2026)House

EPINEPHRINE DELIVERY DEVICE

Sponsored By: Joyce Mason (Democratic)

In Committee

prescription drug affordability & accessibilityassignmentsinsurance

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Joyce Mason

    Democratic • House

Cosponsors

  • Camille Y. Lilly

    Democratic • House

  • Dagmara Avelar

    Democratic • House

  • Harry Benton

    Democratic • House

  • Janet Yang Rohr

    Democratic • House

  • Jawaharial Williams

    Democratic • House

  • Martha Deuter

    Democratic • House

  • Michelle Mussman

    Democratic • House

  • Suzy Glowiak Hilton

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 123 • No: 0

House vote • 2/25/2026

Third Reading - Short Debate - Passed

Yes: 105 • No: 0

House vote • 2/11/2026

Approved for Consideration Rules Committee;

Yes: 5 • No: 0

House vote • 3/19/2025

Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee;

Yes: 13 • No: 0

Actions Timeline

  1. Assigned to Insurance

    4/28/2026Senate

  2. Referred to Assignments

    3/26/2026Senate

  3. First Reading

    3/26/2026Senate

  4. Chief Senate Sponsor Sen. Suzy Glowiak Hilton

    3/26/2026Senate

  5. Added Chief Co-Sponsor Rep. Janet Yang Rohr

    3/9/2026House

  6. Added Co-Sponsor Rep. Michelle Mussman

    3/2/2026House

  7. Placed on Calendar Order of First Reading March 3, 2026

    2/26/2026Senate

  8. Arrive in Senate

    2/26/2026Senate

  9. Third Reading - Short Debate - Passed 105-000-000

    2/25/2026House

  10. Placed on Calendar Order of 3rd Reading - Short Debate

    2/25/2026House

  11. Placed on Calendar 2nd Reading - Short Debate

    2/13/2026House

  12. Approved for Consideration Rules Committee; 005-000-000

    2/11/2026House

  13. Added Chief Co-Sponsor Rep. Martha Deuter

    1/21/2026House

  14. Rule 19(a) / Re-referred to Rules Committee

    4/11/2025House

  15. Added Co-Sponsor Rep. Camille Y. Lilly

    4/8/2025House

  16. Held on Calendar Order of Second Reading - Short Debate

    3/26/2025House

  17. Second Reading - Short Debate

    3/26/2025House

  18. Added Co-Sponsor Rep. Dagmara Avelar

    3/26/2025House

  19. Added Co-Sponsor Rep. Harry Benton

    3/26/2025House

  20. Added Co-Sponsor Rep. Jawaharial Williams

    3/26/2025House

  21. Placed on Calendar 2nd Reading - Short Debate

    3/20/2025House

  22. Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000

    3/19/2025House

  23. Assigned to Prescription Drug Affordability & Accessibility Committee

    3/11/2025House

  24. Referred to Rules Committee

    2/18/2025House

  25. First Reading

    2/18/2025House

Bill Text

Related Bills

Back to State Legislation